The Clinical Diagnostics Division (erstwhile Life Sciences Division) was conceptualized in 2003 as a life science research and diagnostics solutions arm for DSS Imagetech Pvt. Ltd. Today with Abbott Molecular & Dako (Agilent Pathology Solutions) at its forefront, the Clinical Diagnostics Division primarily focusses on clinical diagnostics and is among the leaders in the Molecular Diagnostics market in India.
The Division provides solutions for cancer diagnosis and pre & post-natal genetic aberration diagnosis as well as diagnosis of infectious diseases like HIV, HBV, HCV, CMV, CT/NG, Sepsis, etc.
Through its various principals, DSS covers technologies such as FISH, IHC, RealTime PCR based Viral Load Testing, Integrated Chromosome Profiling (ICP), MLPA, DNA Flow Technology, karyotyping, culture media etc.
This division aims to achieve high growth in the coming years by taking advantage of its prime position in the molecular testing market in India by introducing more tests for diseases which are relevant to the Indian conditions.
The Abbott RealTime CT/NG assay is an in vitro polymerase chain reaction (PCR) assay for the direct, qualitative detection of the plasmid DNA for Chlamydia trachomatis and the genomic DNA of Neisseria gonorrhoeae in female endocervical or vaginal swab specimens, male urethral swab specimens, or male and female urine specimens.
The Abbott RealTime HCV assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for the quantitation of hepatitis C viral ribonucleic acid (HCV RNA) in human serum and plasma from HCV-infected individuals.
The Abbott RealTime HCV Genotype II is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for determining the genotype(s) of hepatitis C virus (HCV) in plasma and serum from HCV-infected individuals.
The Abbott RealTime HIV-1 assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for the quantitation of Human Immunodeficiency Virus type 1 (HIV-1) on the automated m2000 System in human plasma from HIV-1 infected individuals over the range of 40 to 10,000,000 copies/mL. The Abbott RealTime HIV-1 assay is intended for use in conjunction with clinical presentation and other laboratory markers for disease prognosis and for use as an aid in assessing viral response to antiretroviral treatment as measured by changes in plasma HIV-1 RNA levels.
The Abbott RealTime HIV-1 Qualitative assay aids laboratories and physicians in diagnosing HIV-1 infections in pediatric and adult patients, providing usage of innovative DBS sampling and reliable detection of all HIV-1 groups and subtypes.
The Abbott RealTime MTB RIF/INH Resistance assay is an in vitro polymerase chain reaction (PCR) assay for the qualitative detection of Rifampicin (RIF) and Isoniazid (INH) resistance in MTB positive samples.
AneuVysion, which utilizes patented fluorescence in situ hybridization (FISH) technology applied to uncultured amniocytes, provides detection of trisomies 13, 18, and 21 (Down syndrome) and sex chromosome aneusomies in as little as 24 hours.
Autostainer Link 48 provides labs with software and connectivity options that will greatly improve workload management and report generation while maintaining optimal immunohistochemistry staining results.
BMGS (Bone Marrow Growth Supplement) is a ProCell Cytogenetics Reagent that has a marked stimulatory effect on cell growth and morphology in Bone Marrow samples by exposing the cells in culture to a complex mixture of known growth promoters.
BRCA Complete™ Expanded Panel is a complete next generation sequencing (NGS) solution for detecting clinically relevant BRCA1 and BRCA2 mutations along with extended coverage of CHEK2, PALB2, RAD51C and TP53.